The global ophthalmic lasers market is
anticipated to reach USD 1.6 billion by 2025, according to a new report by
Grand View Research, Inc. Ophthalmic disorders are rising significantly on a
global level. This rise in the prevalence rate has led to high growth of
ophthalmic lasers market.
According to American Academy of
Ophthalmology 2014 statistics, nearly 4.2 million people in the U.S. are
visually impaired. Huge number of people suffering from visual impairment are
likely to heighten the demand for ophthalmic lasers in the coming years.
Vision loss is a serious problem
among people suffering from glaucoma, cataract, age-related macular
degeneration (AMD), and diabetic retinopathy. This commonly occurs among the
geriatric population. American Academy of Ophthalmology stated that, around 1.3
million U.S. population are blind. Hence, in order to minimize such huge rate
of vision loss, there is a high need for the application of ophthalmic laser
technology.
Geriatric population are the
primary target for the market. Majority of the chronic ophthalmic disorders,
for instance, cataract and AMD occur among this group of population. However,
refractive errors are also very common among the young people. Thus, growing
number of victims of chronic eye diseases has led to an expected growth of the
market.
Browse full research report on Global
Ophthalmic Lasers Market: http://www.grandviewresearch.com/industry-analysis/ophthalmic-lasers-market
Further key findings from the study suggest:
- In 2016, femtosecond lasers dominated the market due to rising prevalence of refractive errors among both geriatric and young population
- Amongst the application segment, refractive error corrections held the largest market share in 2016 due to large number of surgeries conducted for refractive errors
- Cataract removal is anticipated to show lucrative growth over the forecast period owing to the rising prevalence of cataract removal surgeries among the geriatric people
- In 2016, hospitals contributed towards the largest revenue share owing to the emergence of large number of hospitals in developing economies
- North America dominated the market in 2016 due to rising prevalence of ophthalmic disorders in this region
- Asia Pacific is expected to show lucrative growth over the forecast period owing to the increase in awareness levels among people in developing countries about various treatments for chronic eye disorders
- Few major companies include Carl Zeiss Meditec AG, Abbott Medical Optics, Inc., Alcon Laboratories, Inc., Ellex Medical Lasers Limited, Lumenis, and Bausch & Lomb Incorporated.
Browse more reports of this category by Grand View
Research: http://www.grandviewresearch.com/industry/medical-devices
Grand View Research has segmented the ophthalmic lasers market
on the basis of product, application, end-use, and region:
Ophthalmic Lasers Product Outlook (Revenue, USD Million,
2014 - 2025)
- Diode Lasers
- Femtosecond Lasers
- Excimer Lasers
- Nd:YAG lasers
- SLT Lasers
- Others
Ophthalmic Lasers Application Outlook (Revenue, USD
Million, 2014 - 2025)
- Glaucoma
- Cataract Removal
- Refractive Error Corrections
- Diabetic Retinopathy
- AMD
- Others
Ophthalmic Lasers End-use Outlook (Revenue, USD Million,
2014 - 2025)
- Hospitals
- Ambulatory Surgical Centers
- Ophthalmic Clinics
Ophthalmic Lasers Regional Outlook (Revenue, USD Million,
2014 - 2025)
- North America
- U.S.
- Canada
- Europe
- Germany
- UK
- Asia Pacific
- Japan
- China
- India
- Latin America
- Brazil
- Mexico
- MEA
- South Africa
About Grand View Research
Grand View Research, Inc. is a
U.S. based market research and consulting company, registered in the State of California
and headquartered in San Francisco. The company provides syndicated
research reports, customized research reports, and consulting services. To help
clients make informed business decisions, we offer market intelligence studies
ensuring relevant and fact-based research across a range of industries, from
technology to chemicals, materials and healthcare.
For more information: www.grandviewresearch.com
No comments:
Post a Comment